PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
This Quarter Return
+0.61%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$2.08B
AUM Growth
+$2.08B
(-7.5%)
Cap. Flow
-$67.1M
Cap. Flow
% of AUM
-3.22%
Top 10 Holdings %
Top 10 Hldgs %
77.47%
Holding
49
New
4
Increased
17
Reduced
7
Closed
2
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$65.1M |
| 2 |
EPZM
Epizyme, Inc
EPZM
|
$26.4M |
| 3 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$23.3M |
| 4 |
Karyopharm Therapeutics
KPTI
|
$14.3M |
| 5 |
MDVN
MEDIVATION, INC.
MDVN
|
$14M |
Top Sells
| 1 |
THOR
THORATEC CORPORATION
THOR
|
$145M |
| 2 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$61.7M |
| 3 |
CYBX
CYBERONICS INC
CYBX
|
$24.5M |
| 4 |
KYTH
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
|
$12.4M |
| 5 |
ENDP
Endo International plc
ENDP
|
$4.39M |
Sector Composition
| 1 | Healthcare | 72.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANAC
1
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $304M | 14.6% | 2,579,154 -523,873 | -17% | -$61.7M |
|
|
CLVS
2
DELISTED
Clovis Oncology, Inc.
CLVS
| $286M | 13.75% | 3,108,808 +707,691 | +29% | +$65.1M |
|
|
ABMD
3
DELISTED
Abiomed Inc
ABMD
| $262M | 12.61% | 2,827,005 +84,700 | +3% | +$7.86M |
|
4
United Therapeutics
UTHR
$13.8B
| $200M | 9.62% | 1,524,254 +84,326 | +6% | +$11.1M |
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $176M | 8.44% | 1,666,492 +6,400 | +0.4% | +$674K |
|
|
AMAG
6
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $110M | 5.31% | 2,777,392 +585,251 | +27% | +$23.3M |
|
7
Insmed
INSM
$28.8B
| $88.6M | 4.26% | 4,768,800 +35,199 | +0.7% | +$654K |
|
|
KYTH
8
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $84.4M | 4.06% | 1,125,564 -164,728 | -13% | -$12.4M |
|
|
ENDP
9
DELISTED
Endo International plc
ENDP
| $55.5M | 2.67% | 801,230 -63,374 | -7% | -$4.39M |
|
10
Vanda Pharmaceuticals
VNDA
$279M
| $45.1M | 2.17% | 3,997,108 +99,700 | +3% | +$1.12M |
|
|
WMGI
11
DELISTED
Wright Medical Group Inc
WMGI
| $43.2M | 2.08% | 2,056,251 | – | – |
|
|
12
Karyopharm Therapeutics
KPTI
$61.7M
| $32.5M | 1.56% | 3,085,745 +1,354,215 | +78% | +$14.3M |
|
13
Prothena Corp
PRTA
$441M
| $31.6M | 1.52% | 695,918 | – | – |
|
14
Gilead Sciences
GILD
$140B
| $31.1M | 1.5% | 316,900 +17,400 | +6% | +$1.71M |
|
|
CELG
15
DELISTED
Celgene Corp
CELG
| $29.3M | 1.41% | 270,800 +8,600 | +3% | +$930K |
|
16
Amicus Therapeutics
FOLD
$2.34B
| $27.6M | 1.33% | 1,974,376 | – | – |
|
|
EPZM
17
DELISTED
Epizyme, Inc
EPZM
| $27.2M | 1.31% | 2,115,638 +2,054,373 | +3,353% | +$26.4M |
|
|
MNTA
18
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $23.9M | 1.15% | 1,455,176 | – | – |
|
|
MDVN
19
DELISTED
MEDIVATION, INC.
MDVN
| $21.7M | 1.04% | 509,862 +329,562 | +183% | +$14M |
|
|
SHPG
20
DELISTED
Shire pic
SHPG
| $21.5M | 1.03% | 104,700 +6,400 | +7% | +$1.31M |
|
21
STAAR Surgical
STAA
$1.36B
| $20.5M | 0.99% | 2,642,922 | – | – |
|
|
ZLTQ
22
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $18.2M | 0.88% | 568,436 | – | – |
|
|
SQNM
23
DELISTED
SEQUENOM INC NEW
SQNM
| $17.5M | 0.84% | 10,023,842 | – | – |
|
|
THOR
24
DELISTED
THORATEC CORPORATION
THOR
| $17M | 0.82% | 268,861 -2,291,442 | -89% | -$145M |
|
25
Intuitive Surgical
ISRG
$170B
| $13.4M | 0.64% | 29,100 -3,250 | -10% | -$1.49M |
|